PHASE I-II TRIAL - LABELED MONOCLONAL-ANTIBODY TO CEA IN PATIENTS WITH COLORECTAL-CANCER

被引:0
|
作者
LEVINE, G
TAUXE, WN
KIRKWOOD, JM
ERNSTOFF, MS
UNGER, M
KOWAL, CD
机构
[1] UNIV PITTSBURGH,DEPT MED,PITTSBURGH,PA 15219
[2] UNIV PITTSBURGH,DEPT PHARMACOL,PITTSBURGH,PA 15219
[3] UNIV PITTSBURGH,DEPT RADIOL,PITTSBURGH,PA 15219
[4] PITTSBURGH CANC INST,PITTSBURGH,PA 15219
[5] HYBRITECH INC,LA JOLLA,CA 92121
来源
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1988年 / 29卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:175 / 175
页数:1
相关论文
共 50 条
  • [31] LACTOSYLSPHINGOSINE-REACTIVE ANTIBODY AND CEA IN PATIENTS WITH COLORECTAL-CANCER
    JOZWIAK, W
    KOSCIELAK, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (07): : 617 - 621
  • [32] ANTI-CEA MONOCLONAL-ANTIBODY TC-99M-BW 431/26 IN THE DIAGNOSTIC WORKUP OF PATIENTS WITH COLORECTAL-CANCER
    FRAILE, M
    BUXEDA, M
    CASTELL, J
    TORRES, M
    JIMENEZHEFFERNAN, A
    MATEO, A
    SORIANO, B
    DOMENECHTORNE, FM
    NUCLEAR MEDICINE AND BIOLOGY, 1991, 18 (01): : 53 - &
  • [33] Phase II study of dual I-131-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer
    Meredith, RF
    Khazaeli, MB
    Plott, WE
    Grizzle, WE
    Liu, TP
    Schlom, J
    Russell, CD
    Wheeler, RH
    LoBuglio, AF
    CLINICAL CANCER RESEARCH, 1996, 2 (11) : 1811 - 1818
  • [34] A NEW MONOCLONAL-ANTIBODY FOR RADIOIMMUNOSCINTIGRAPHY, RIS, OF COLORECTAL-CANCER - PR1A3 LABELED WITH IN-111
    GRANOWSKA, M
    RICHMAN, P
    BRITTON, KE
    MATHER, SJ
    SOBNACK, R
    JASS, JR
    CLAYTON, S
    NORTHOVER, JMA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 223 - 223
  • [35] AUTORADIOGRAPHIC ANALYSIS OF RADIOLABELED ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODY CEA102 IN COLORECTAL-CANCER USING COMPUTED RADIOGRAPHY
    SATOH, T
    WATANABE, T
    TADOKORO, M
    SAKAMOTO, J
    MURAYAMA, H
    ITOH, K
    SAKUMA, S
    TAKAGI, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (04): : 379 - 386
  • [36] A COMPARISON OF IN-111 ANTI CEA WITH IN-111 PR1A3 MONOCLONAL-ANTIBODY IN COLORECTAL-CANCER
    GRANOWSKA, M
    BRITTON, KE
    RICHMAN, P
    MATHER, SJ
    JASS, JR
    SOBNACK, R
    NORTHOVER, JMA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (7-8): : C5 - C5
  • [37] PHASE I/II STUDY OF IODINE 131-LABELED MONOCLONAL-ANTIBODY A33 IN PATIENTS WITH ADVANCED COLON-CANCER
    WELT, S
    DIVGI, CR
    KEMENY, N
    FINN, RD
    SCOTT, AM
    GRAHAM, M
    STGERMAIN, J
    RICHARDS, EC
    LARSON, SM
    OETTGEN, HF
    OLD, LJ
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (08) : 1561 - 1571
  • [38] RADIOLABELED MONOCLONAL-ANTIBODY B72.3 LOCALIZATION IN METASTATIC LESIONS OF COLORECTAL-CANCER PATIENTS
    COLCHER, D
    CARRASQUILLO, JA
    ESTEBAN, JM
    SUGARBAKER, P
    REYNOLDS, JC
    SILER, K
    BRYANT, G
    LARSON, SM
    SCHLOM, J
    NUCLEAR MEDICINE AND BIOLOGY, 1987, 14 (03): : 251 - &
  • [39] A phase I/II trial of vaccination with a novel murine monoclonal anticarotid endarterectomy (CEA) antibody in patients with advanced colorectal cancer (vol 86, pg 102, 1999)
    Zbar, AP
    Thomas, H
    Snary, D
    Wilkinson, RW
    Ross, EL
    Wadhwa, M
    Allen-Mersh, TG
    Kmiot, WA
    BRITISH JOURNAL OF SURGERY, 1999, 86 (07) : 960 - 960
  • [40] MURINE ANTIIDIOTYPE (ID) MONOCLONAL-ANTIBODY (MAB) BREAKS TOLERANCE AND INDUCES A SPECIFIC ANTIBODY-RESPONSE TO CARCINOEMBRYONIC ANTIGEN (CEA) IN COLORECTAL-CANCER (CRC) PATIENTS
    BHATTACHARYACHATTERJEE, M
    CHAKRABORTY, M
    KOHLER, H
    SHERRATT, AJ
    FOON, KA
    FASEB JOURNAL, 1994, 8 (04): : A200 - A200